Share Icon Health Study Area: Cardiovascular Disease Chevron Icon Health Study Area: Genitourinary For Patients Health Study Area: Lung Cancer Page Icon Phone Icon For Caregivers Health Study Area: AutoImmune Disease Health Study Area: Melanoma Location Icon Print YouTube Icon For Parents Health Study Area: Lung Cancer Print Created with Sketch. Help Icon Green Check Icon Search Icon Instagram Created with sketchtool. Direction Arrow Icon Error Icon For Parents Health Study Area: Blood Cancer Help Icon Health Study Area: NASH Gender Both Bookmark Icon Health Study Area: Melanoma Created with Sketch. Glossary Print Health Study Area: Blood Cancer Health Study Area: Genitourinary Health Study Area: Gastrointestinal Cancer Mobile Menu Icon Created with Sketch. Health Study Area: Cardiovascular Disease Health Study Area: Women's Cancer Communities Map Icon Created with Sketch. For Caregivers Health Study Area: Fibrosis Health Study Area: AutoImmune Disease FAQs Health Study Area: Head and Neck Cancer Created with Sketch. For Clinicians Chevron Right Icon Gender Female Health Study Area: Breast Cancer Direction Arrow Icon Gender Both Right Arrow Icon LinkedIn Icon Green Check Icon Gender Male Health Study Area: Fibrosis For Patients Twitter Icon Email Icon Facebook Icon Health Study Area: Gastrointestinal Cancer Health Study Area: Head and Neck Cancer For Clinicians External Link Icon

KRYSTAL Clinical Trials

BMS is conducting clinical trials in non-small cell lung cancer using adagrasib as the investigational study drug

3D rendering of a lung cancer cell displaying red with blue and purple spots, illustrating the KRAS G12C mutation.

Phase 3 clinical trials investigating the addition of adagrasib to standard of care treatments in patients with advanced non-small cell lung cancer (NSCLC) with KRASG12C mutation

KRYSTAL clinical trials are currently open for enrollment

Find Out More Proposed mechanism of action of adagrasib in NSCLC

Explore KRYSTAL clinical studies in NSCLC

Clinical Trial Locator Tool Icon

Find a KRYSTAL clinical trial site by location​

This website provides general information about ongoing BMS clinical trials and a source of scientific information related to BMS investigational product adagrasib. The information included pertains to an investigational therapy that has not yet been approved for use in any country. The safety and efficacy of investigational therapies and/or uses have not been established. There is no guarantee that the agents will receive health authority approval or become commercially available in any country for the uses being investigated.

© 2025 Bristol Myers Squibb Company. All rights reserved.